NR3C1 and asthma: Further modification of VSG22 based on additional structural insight gained from the structures of the cortisol- and DEX-bound GR LBD allowed us to generate a highly potent glucocorticoid, VSGC12, which has ideal properties for asthma treatments reported in this paper.